echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Under the promotion of national harvest, the generic "knockout" to open the acceleration mode.

    Under the promotion of national harvest, the generic "knockout" to open the acceleration mode.

    • Last Update: 2020-07-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network Industry Dynamics Recently, Shaanxi Province Pharmaceutical Sourcing Platform issued "On the national organization of centralized procurement of drugs and the use of pilot expansion of the regional scope of the relevant varieties of the announcement II." The announcement shows that a drug through the audit to meet the requirements of the network and a drug because of the evaluation is greater than the home was disqualified from the networkAccording to the shaanxi provincial public medical institutions must be through the provincial procurement platform online procurement of drugs must not be off-line or non-prescribed channels to purchase drugs regulations, will be stopped on the internet is a basic farewell to the Shaanxi marketIn fact, in addition to Shaanxi Province this year, many drugs can be said to have ushered in the withdrawal of the tide: the evening of the month Shandong Province Public Resources Trading Center issued "on the publicity of the state organization centralized procurement of the first batch of unselected drug price adjustment notice" announced a drug adjusted price of drugs to withdraw the network of drugs to suspend tradingThe proposed withdrawal of the network of drugs involving a variety of drugs from the domestic pharmaceutical production enterprises have a drug is due to the product repeat was removed from the network of the remaining drugs have been withdrawn the network involving a large number of well-known enterprises large varietiesOn the second month of Jiangsu Province, the Public Resources Trading Center issued a "notice on the public suspension of the purchase of parts of the non-passed generic drug quality and efficacy consistency evaluation of drugs" suspended the procurement of a drug, including amoxicillin capsules, omeprazole intestinal capsules, oxalic acid Aesisiplantablet tablets, meloxicon tablets, sodium bicarbonate tablets, cephalosporine capsules, left ethyl lasitan tablets and so onOn the same day, Shenzhen Pharmaceutical Trading Platform suspended the purchase of a drug that had not been evaluated by a single one, involving attovastatin calcium tablets, benzodiazepine tablets, amoxicillin capsules, acetaminophen tablets, methazole tablets, pyrapamine tabletsOn the month of beijing Pharmaceutical Collection and Collection Service Center issued "on the suspension of the national collection within the scope of some of the failure to pass the consistency evaluation of product procurement function notice" was suspended procurement of as many varieties involving a number of well-known pharmaceutical companies such as Jiangsu Hengrui, Shi pharma Ouyi, Sichuan Collum, Shijiazhuang four drugs, Lizhu Group, Shanghai Medicine, Baiyunshan and so onFrom the above case comprehensive point of view, the high probability of drugs stopped hanging the net is still mainly to the varieties that failed the consistency evaluation and the evaluation has been full of threeIn fact, in the "on the implementation of generic drug quality and efficacy consistency evaluation of the opinionissue issued by the State Office" issued in the year has been explicitly requested that the same varieties of drugs through consistency evaluation of the production enterprises to reach more than home in the centralized procurement of drugs and other aspects of the selection of non-conformity evaluation of the varietiesRecently through the collection of documents around the local collection can also obviously find that the local collection of commonly used drugs for clinical collection trend around the practice seems to prove that the unselected varieties, not over-consistent evaluation of drugs in the market share and price will inevitably be subject to a greater degree of damage, especially not the consistent evaluation of varietiesIn general, generic drug consistency evaluation policy and document intensive introduction of national band procurement is the promotion of generic drugs "elimination" to open the accelerated modelIn this case, many pharmaceutical companies have become more and more aware that generic consistency evaluation will be the general trendAnd with the consistency evaluation of more and more varieties after the three-year period for many pharmaceutical companies is a pressure is also the driving force of continuous progressAnd the review should be done not only but also done earlyOtherwise, pharmaceutical companies' products will soon lose their competitiveness in entering the market
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.